The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Building for Success! The journey of introducing a new therapy to the market involves more than just its development. Join our upcoming session to explore the critical role of facility design and construction in the success of a therapy. Our esteemed speakers will share their experiences through compelling case studies, providing invaluable insights into the entire process, from the initial stages of therapy development to the later phases of facility design and construction. Don't miss this opportunity to gain a comprehensive understanding of how to navigate the path to market for a successful therapy.
1000 - 1030: FOYA Operations: Resilient Project Execution, Design-Assist Model Success by Gene Russell and Brendan McGrath 1030 - 1100: Vertex Pharmaceuticals: Pioneering Cell Therapies for the Next Generation by Emily Heffernan and Mark Melilli 1100 - 1130: Building cGMP Facilities in Challenging Times by Laura Whelan, Sal Ceja, Nima Payan, and Nino Adamo
Speaker(s):
Nino
Adamo,
Vice President and General Manager,
Turner Construction Co
Sal
Ceja,
Principal, Architect, AIA, LEED AP,
EwingCole
Emily
Heffernan,
PE,
US Director, New Process Technology,
Arcadis DPS Group
Brendan
McGrath,
Site Head & Vice President Manufacturing,
WuXi Biologics (Shanghai) Co., Ltd.
Mark
R. Melilli,
Cell & Gene Therapy Advanced Manufacturing Lead,
Vertex Pharmaceuticals
Nima
Payan,
Chief Operating Officer,
SPIN Biotech Consulting LLC
Gene
Russell,
Senior Director, Head of Engineering,
WuXi Biologics
Laura
Whelan,
Executive Vice President, Project Management Services,
Savills North America